A carregar...
APOA-I: A Possible Novel Biomarker for Metabolic Side Effects in First Episode Schizophrenia
The purpose of this study was to investigate the change in plasma protein expression in first episode schizophrenia after an 8-week treatment with risperidone, and to explore potential biomarkers for metabolic side effects associated with risperidone treatment. Eighty first-episode schizophrenia pat...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3978061/ https://ncbi.nlm.nih.gov/pubmed/24710015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0093902 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|